275 related articles for article (PubMed ID: 25911236)
1. Serum Levels of Biomarkers of Immune Activation and Associations With Neurological Impairment in Relapsing-Remitting Multiple Sclerosis Patients During Remission.
Witkowska AM; Socha K; Kochanowicz J; Karpińska E; Jakoniuk M; Zujko ME; Wilkiel M; Borawska MH; Mariak Z
Biol Res Nurs; 2016 Jan; 18(1):113-9. PubMed ID: 25911236
[TBL] [Abstract][Full Text] [Related]
2. Serum soluble adhesion molecules in multiple sclerosis: raised sVCAM-1, sICAM-1 and sE-selectin in primary progressive disease.
McDonnell GV; McMillan SA; Douglas JP; Droogan AG; Hawkins SA
J Neurol; 1999 Feb; 246(2):87-92. PubMed ID: 10195402
[TBL] [Abstract][Full Text] [Related]
3. [Clinical course and changes of soluble interleukin-2 receptor and soluble forms of intercellular adhesion molecule-1 (ICAM-1) in serum of multiple sclerosis patients].
Bilińska M; Frydecka I; Podemski R
Neurol Neurochir Pol; 2001; 35(1):47-56. PubMed ID: 11464716
[TBL] [Abstract][Full Text] [Related]
4. Circulating soluble adhesion molecules in patients with giant cell arteritis. Correlation between soluble intercellular adhesion molecule-1 (sICAM-1) concentrations and disease activity.
Coll-Vinent B; Vilardell C; Font C; Oristrell J; Hernández-Rodríguez J; Yagüe J; Urbano-Márquez A; Grau JM; Cid MC
Ann Rheum Dis; 1999 Mar; 58(3):189-92. PubMed ID: 10364919
[TBL] [Abstract][Full Text] [Related]
5. Soluble adhesion molecules and interleukin-2 receptor concentrations in patients with autoimmune chronic hepatitis.
Simpson KJ; Jones AL; Forbes Howie A; Hayes PC
Eur J Gastroenterol Hepatol; 1995 May; 7(5):455-60. PubMed ID: 7542148
[TBL] [Abstract][Full Text] [Related]
6. Raised CSF levels of soluble adhesion molecules across the clinical spectrum of multiple sclerosis.
McDonnell GV; McMillan SA; Douglas JP; Droogan AG; Hawkins SA
J Neuroimmunol; 1998 May; 85(2):186-92. PubMed ID: 9630167
[TBL] [Abstract][Full Text] [Related]
7. Circulating selectins, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in hyperthyroidism.
Wenisch C; Myskiw D; Gessl A; Graninger W
J Clin Endocrinol Metab; 1995 Jul; 80(7):2122-6. PubMed ID: 7541802
[TBL] [Abstract][Full Text] [Related]
8. Serum levels of soluble adhesion molecules ICAM-1, VCAM-1 and E-selectin in patients with Wegener's granulomatosis.
Ohta N; Fukase S; Aoyagi M
Auris Nasus Larynx; 2001 Nov; 28(4):311-4. PubMed ID: 11694374
[TBL] [Abstract][Full Text] [Related]
9. Circulating levels of soluble E-selectin, P-selectin and intercellular adhesion molecule-1 in patients with juvenile idiopathic arthritis.
De Benedetti F; Vivarelli M; Pignatti P; Oliveri M; Massa M; Pistorio A; Martini A
J Rheumatol; 2000 Sep; 27(9):2246-50. PubMed ID: 10990242
[TBL] [Abstract][Full Text] [Related]
10. Soluble intercellular adhesion molecule-1 in serum and cerebrospinal fluid of clinically active relapsing-remitting multiple sclerosis: correlation with Gd-DTPA magnetic resonance imaging-enhancement and cerebrospinal fluid findings.
Trojano M; Avolio C; Simone IL; Defazio G; Manzari C; De Robertis F; Calò A; Livrea P
Neurology; 1996 Dec; 47(6):1535-41. PubMed ID: 8960741
[TBL] [Abstract][Full Text] [Related]
11. Circulating intercellular adhesion molecule-1 and E-selectin levels in gastric cancer.
Benekli M; Güllü IH; Tekuzman G; Savaş MC; Hayran M; Hasçelik G; Firat D
Br J Cancer; 1998 Jul; 78(2):267-71. PubMed ID: 9683305
[TBL] [Abstract][Full Text] [Related]
12. Soluble intercellular adhesion molecule-1 and soluble E-selectin levels in patients with atopic dermatitis.
Hirai S; Kageshita T; Kimura T; Tsujisaki M; Okajima K; Imai K; Ono T
Br J Dermatol; 1996 Apr; 134(4):657-61. PubMed ID: 8733366
[TBL] [Abstract][Full Text] [Related]
13. Evidence for the regulation of levels of plasma adhesion molecules by proinflammatory cytokines and their soluble receptors in type 1 diabetes.
Mohamed-Ali V; Armstrong L; Clarke D; Bolton CH; Pinkney JH
J Intern Med; 2001 Nov; 250(5):415-21. PubMed ID: 11887976
[TBL] [Abstract][Full Text] [Related]
14. Adhesion molecules in multiple sclerosis: relation to subtypes of disease and methylprednisolone therapy.
Elovaara I; Ukkonen M; Leppäkynnäs M; Lehtimäki T; Luomala M; Peltola J; Dastidar P
Arch Neurol; 2000 Apr; 57(4):546-51. PubMed ID: 10768630
[TBL] [Abstract][Full Text] [Related]
15. Elevation of serum soluble intercellular adhesion molecule-1 (sICAM-1) and sE-selectin levels in bronchial asthma.
Kobayashi T; Hashimoto S; Imai K; Amemiya E; Yamaguchi M; Yachi A; Horie T
Clin Exp Immunol; 1994 Apr; 96(1):110-5. PubMed ID: 7512004
[TBL] [Abstract][Full Text] [Related]
16. [Relation of serum levels of the soluble cytoadhesion molecules sVCAM-1 and sICAM-1 to selected factors in the cytokine network in multiple myeloma].
Scudla V; Budíková M; Bacovský J; Opíchalová D; Farbiaková V
Cas Lek Cesk; 2000 Jul; 139(13):401-6. PubMed ID: 10971970
[TBL] [Abstract][Full Text] [Related]
17. Serial analysis of circulating adhesion molecules and TNF receptor in serum from patients with multiple sclerosis: cICAM-1 is an indicator for relapse.
Rieckmann P; Martin S; Weichselbraun I; Albrecht M; Kitze B; Weber T; Tumani H; Broocks A; Lüer W; Helwig A
Neurology; 1994 Dec; 44(12):2367-72. PubMed ID: 7527508
[TBL] [Abstract][Full Text] [Related]
18. Comparison of soluble adhesion molecules in juvenile idiopathic arthritis between the active and remission stages.
Chen CY; Tsao CH; Ou LS; Yang MH; Kuo ML; Huang JL
Ann Rheum Dis; 2002 Feb; 61(2):167-70. PubMed ID: 11796405
[TBL] [Abstract][Full Text] [Related]
19. Changes in serum levels of ICAM and TNF-R correlate with disease activity in multiple sclerosis.
Khoury SJ; Orav EJ; Guttmann CR; Kikinis R; Jolesz FA; Weiner HL
Neurology; 1999 Sep; 53(4):758-64. PubMed ID: 10489037
[TBL] [Abstract][Full Text] [Related]
20. Serum levels of soluble intercellular adhesion molecule-1 and E-selectin in metastatic breast carcinoma: correlations with clinicopathological features and prognosis.
Zhang GJ; Adachi I
Int J Oncol; 1999 Jan; 14(1):71-7. PubMed ID: 9863011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
